CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
NeoSync EEG Synchronization Therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01683019
NCT01683019N/ACompleted
CompareCT.gov

A MULTICENTER, RANDOMIZED, BLINDED, SHAM CONTROLLED, PARALLEL GROUP TRIAL TO TEST CLINICAL EFFICACY OF LOW FREQUENCY AC MAGNETIC FIELD INDUCED EEG SYNCHRONIZATION IN MAJOR DEPRESSION

Wave Neuroscience·interventional·Posted Sep 11, 2012·Updated Dec 7, 2018

In Brief

A clinical study evaluating NeoSync EEG Synchronization Therapy and Sham NeoSync EEG Synchronization Therapy for Major Depressive Disorder (MDD). Completed, enrolled 52 participants across 2 sites in 2 countries.

Detailed Summary

This feasibility study investigates effects of EEG-based low frequency, low emission magnetic cortical stimulation in comparison to a sham treatment in subjects with moderate to severe depressive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder (MDD)
CountriesChina, United States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 11, 2012
Enrollment StartJun 1, 2008
Primary CompletionNov 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.8 years ago

Interventions

NeoSync EEG Synchronization Therapydevice

Generate low-energy sinusoidal magnetic field above the scalp with frequency equal to the subject's intrinsic alpha frequency (IAF). Treatment is 30 minutes, administered 5 days per week for 4 weeks.

Sham NeoSync EEG Synchronization Therapydevice

A device that looks and sounds similar to the active treatment, but no magnetic field is generated.